Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia
- PMID: 16155196
- PMCID: PMC2563220
- DOI: 10.1136/jmg.2005.035451
Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia
Abstract
Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by vascular malformations in multiple organ systems, resulting in mucocutaneous telangiectases and arteriovenous malformations predominantly in the lungs (pulmonary arteriovenous malformation; PAVM), brain (cerebral arteriovenous malformation; CAVM), and liver (hepatic arteriovenous malformation; HAVM). Mutations in the ENG and ALK-1 genes lead to HHT1 and HHT2 respectively. In this study, a genotype-phenotype analysis was performed. A uniform and well classified large group of HHT patients and their family members were screened for HHT manifestations. Groups of patients with a clinically confirmed diagnosis and/or genetically established diagnosis (HHT1 or HHT2) were compared. The frequency of PAVM, CAVM, HAVM, and gastrointestinal telangiectases were determined to establish the genotype-phenotype relationship. The analysis revealed differences between HHT1 and HHT2 and within HHT1 and HHT2 between men and women. PAVMs and CAVMs occur more often in HHT1, whereas HAVMs are more frequent in HHT2. Furthermore, there is a higher prevalence of PAVM in women compared with men in HHT1. In HHT1 and HHT2, there is a higher frequency of HAVM in women. HHT1 has a distinct, more severe phenotype than HHT2. There is a difference in the presence of symptoms between men and women. With these data, genetic counselling can be given more accurately when the family mutation is known.
Conflict of interest statement
Competing interests: there are no competing interests.
Similar articles
-
Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.J Thromb Haemost. 2007 Jun;5(6):1149-57. doi: 10.1111/j.1538-7836.2007.02531.x. J Thromb Haemost. 2007. PMID: 17388964
-
Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.Genet Med. 2007 Jan;9(1):14-22. doi: 10.1097/gim.0b013e31802d8373. Genet Med. 2007. PMID: 17224686
-
Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.Am J Med Genet A. 2008 Nov 1;146A(21):2733-9. doi: 10.1002/ajmg.a.32243. Am J Med Genet A. 2008. PMID: 18831062
-
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.J Med Genet. 2006 Feb;43(2):97-110. doi: 10.1136/jmg.2005.030833. Epub 2005 May 6. J Med Genet. 2006. PMID: 15879500 Free PMC article. Review.
-
Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects.Curr Pharm Des. 2006;12(10):1173-93. doi: 10.2174/138161206776361291. Curr Pharm Des. 2006. PMID: 16611099 Review.
Cited by
-
Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasia.EJHaem. 2023 Jul 3;4(3):602-611. doi: 10.1002/jha2.746. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601877 Free PMC article.
-
Endothelial signaling and the molecular basis of arteriovenous malformation.Cell Mol Life Sci. 2013 Sep 28;71(5):867-83. doi: 10.1007/s00018-013-1475-1. Online ahead of print. Cell Mol Life Sci. 2013. PMID: 24077895 Free PMC article.
-
Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry.Orphanet J Rare Dis. 2020 Jun 5;15(1):138. doi: 10.1186/s13023-020-01422-8. Orphanet J Rare Dis. 2020. PMID: 32503579 Free PMC article.
-
Gender differences in hereditary hemorrhagic telangiectasia severity.Orphanet J Rare Dis. 2020 Mar 2;15(1):63. doi: 10.1186/s13023-020-1337-5. Orphanet J Rare Dis. 2020. PMID: 32122373 Free PMC article.
-
Optimal management of hereditary hemorrhagic telangiectasia.J Blood Med. 2014 Oct 15;5:191-206. doi: 10.2147/JBM.S45295. eCollection 2014. J Blood Med. 2014. PMID: 25342923 Free PMC article. Review.
References
-
- Westermann C J, Rosina A F, De Vries V, de Coteau P A. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro‐Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A 2003116324–328. - PubMed
-
- Haitjema T, Balder W, Disch F J, Westermann C J. Epistaxis in hereditary haemorrhagic telangiectasia. Rhinology 199634176–178. - PubMed
-
- Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, Lux A, McKinnon W, Marchuk D, Guttmacher A. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 200340585–590. - PMC - PubMed
-
- Guttmacher A E, Marchuk D A, White R I., Jr Hereditary hemorrhagic telangiectasia. N Engl J Med 1995333918–924. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources